In the tumor microenvironment (TME), IL‐4 elicits an increased Th2 response and activates myeloid‐derived suppressor cells (MDSCs) and tumor‐associated macrophages (TAMs), both of which express the IL‐4R, to promote immunosuppression and angiogenesis [2]. The gene discussed is IL4; the disease is neoplasm.